Their advanced technology, known as optoacoustic imaging (OAI), offers exceptional spatiotemporal resolution, penetration depth, sensitivity, and specificity, making it highly versatile for a wide range of applications. iThera Medical offers both clinical and preclinical research solutions. In clinical research, OAI has shown great promise in areas such as oncology, inflammation, and fibrosis, paving the way for improved clinical diagnoses.

Meanwhile, in preclinical research, OAI has become an established imaging modality, thanks to its unique ability to differentiate endogenous chromophores and exogenous probes. The brand's product lineup includes the MSOT Acuity Echo, a clinical imaging system that provides real-time imaging with anatomical, functional, and molecular contrast. They also offer the RSOM Explorer C50, an optoacoustic mesoscopy system with high-resolution imaging and deep penetration capabilities.

Additionally, there's the MSOT inVision, which offers highly sensitive quantitative optoacoustic imaging with integrated ultrasound CT. Lastly, the RSOM Explorer P50 allows visualization of microvasculature for preclinical research. With a commitment to innovation and advancements in optoacoustic imaging, iThera Medical is at the forefront of this cutting-edge technology, ensuring exciting possibilities for both research and diagnosis in various fields